From the Guidelines
Tubular acidosis with hyperkalemia is generally a type 4 renal tubular acidosis, characterized by a defect in aldosterone secretion or resistance to its action, and the primary treatment involves replacing the deficient aldosterone with fludrocortisone (Florinef) at a dose of 0.1 to 0.2 mg per day, as well as identifying and treating underlying causes, such as discontinuing medications that can exacerbate this condition, and implementing a low-potassium diet. The causes of hyperkalemia can be classified into three main categories:
- Increased potassium intake or administration,
- Decreased potassium excretion, and
- Shift of potassium from the intracellular to the extracellular space. Some of the medications that can cause hyperkalemia include potassium-sparing diuretics, beta-blockers, NSAIDs, and renin-angiotensin-aldosterone system inhibitors (RAASi) 1. To correct acute hyperkalemia, treatments such as intravenous calcium, insulin, and beta-agonists can be used to redistribute potassium into the intracellular space, while loop diuretics and potassium binders can increase potassium elimination 2. It is also important to note that patients with cardiovascular disease and chronic kidney disease are at risk of hyperkalemia, and regular monitoring of serum electrolytes and renal function is necessary to adjust treatment and prevent complications 1. Additionally, a low-potassium diet is recommended, limiting foods such as bananas, oranges, and leafy green vegetables, and salt substitutes that contain potassium should be avoided 3. Overall, the management of hyperkalemia requires a comprehensive approach that includes identifying and treating underlying causes, implementing a low-potassium diet, and using medications to correct acute hyperkalemia and prevent complications. Some key points to consider in the management of hyperkalemia include:
- Identifying and treating underlying causes, such as discontinuing medications that can exacerbate hyperkalemia
- Implementing a low-potassium diet to reduce potassium intake
- Using medications such as fludrocortisone to replace deficient aldosterone
- Correcting acute hyperkalemia with treatments such as intravenous calcium, insulin, and beta-agonists
- Increasing potassium elimination with loop diuretics and potassium binders
- Regularly monitoring serum electrolytes and renal function to adjust treatment and prevent complications.
From the Research
Causes of Tubular Acidosis
- Renal tubular acidosis (RTA) occurs when the kidneys are unable to maintain normal acid-base homeostasis due to tubular defects in acid excretion or bicarbonate ion reabsorption 4
- The three major forms of RTA are distal RTA (type 1), proximal RTA (type 2), and hyperkalemic RTA (type 4) 4
- Type 4 RTA is caused by abnormal excretion of acid and potassium in the collecting duct, often due to selective aldosterone deficiency or resistance to its effects 4
Causes of Hyperkalemia
- Hyperkalemia can be caused by the use of certain drugs, such as ACEIs, ARBs, NSAIDs, aldosterone antagonists, nonselective beta-blockers, heparin, trimetoprim, and calcineurin inhibitors 5
- Abrupt reduction in glomerular filtration rate, constipation, prolonged fasting, and metabolic acidosis can also lead to hyperkalemia 5
- Hyperkalemic RTA (type 4) is a rare form of RTA characterized by impaired excretion of potassium and acid in the collecting duct 4, 6
- Other causes of hyperkalemia include real or apparent hypoaldosteronism caused by diseases or drug toxicity 6
- The rate of change in plasma potassium concentration is critical, and acute hyperkalemia should be urgently treated 7, 8